Literature DB >> 17172591

Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis.

H Sokol, P Lepage, Ph Seksik, J Doré, Ph Marteau.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17172591      PMCID： PMC1856643          DOI： 10.1136/gut.2006.109686

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

Review 1.  Review article: gut flora and inflammatory bowel disease.

Authors:  P Marteau; P Lepage; I Mangin; A Suau; J Doré; P Pochart; P Seksik
Journal:  Aliment Pharmacol Ther       Date:  2004-10       Impact factor: 8.171

2.  Biodiversity of the mucosa-associated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD.

Authors:  Patricia Lepage; Philippe Seksik; Malène Sutren; Marie-France de la Cochetière; Raymond Jian; Philippe Marteau; Joël Doré
Journal:  Inflamm Bowel Dis       Date:  2005-05       Impact factor: 5.325

3.  Search for localized dysbiosis in Crohn's disease ulcerations by temporal temperature gradient gel electrophoresis of 16S rRNA.

Authors:  Philippe Seksik; Patricia Lepage; Marie-France de la Cochetière; Arnaud Bourreille; Malène Sutren; Jean-Paul Galmiche; Joël Doré; Philippe Marteau
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls.

Authors:  B Kleessen; A J Kroesen; H J Buhr; M Blaut
Journal:  Scand J Gastroenterol       Date:  2002-09       Impact factor: 2.423

5.  Temperature gradient gel electrophoresis of fecal 16S rRNA reveals active Escherichia coli in the microbiota of patients with ulcerative colitis.

Authors:  H Sokol; P Lepage; P Seksik; J Doré; P Marteau
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

6.  The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis.

Authors:  M C Pitcher; E R Beatty; J H Cummings
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

7.  Reduction in diversity of the colonic mucosa associated bacterial microflora in patients with active inflammatory bowel disease.

Authors:  S J Ott; M Musfeldt; D F Wenderoth; J Hampe; O Brant; U R Fölsch; K N Timmis; S Schreiber
Journal:  Gut       Date:  2004-05       Impact factor: 23.059
  7 in total
  12 in total

Review 1.  Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.

Authors:  Shivani Ghaisas; Joshua Maher; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2015-11-26       Impact factor: 12.310

Review 2.  Microbial host interactions in IBD: implications for pathogenesis and therapy.

Authors:  R Balfour Sartor; Marcus Muehlbauer
Journal:  Curr Gastroenterol Rep       Date:  2007-12

3.  Crypt abscess-associated microbiota in inflammatory bowel disease and acute self-limited colitis.

Authors:  Harry Sokol; Nadia Vasquez; Nadia Hoyeau-Idrissi; Philippe Seksik; Laurent Beaugerie; Anne Lavergne-Slove; Philippe Pochart; Philippe Marteau
Journal:  World J Gastroenterol       Date:  2010-02-07       Impact factor: 5.742

Review 4.  Colonic biogeography in health and ulcerative colitis.

Authors:  Aonghus Lavelle; Grainne Lennon; Desmond C Winter; P Ronan O'Connell
Journal:  Gut Microbes       Date:  2016-08-11

5.  High throughput sequencing reveals distinct microbial populations within the mucosal and luminal niches in healthy individuals.

Authors:  Yehuda Ringel; Nitsan Maharshak; Tamar Ringel-Kulka; Elizabeth Ashley Wolber; R Balfour Sartor; Ian M Carroll
Journal:  Gut Microbes       Date:  2015

6.  Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.

Authors:  Harry Sokol; Bénédicte Pigneur; Laurie Watterlot; Omar Lakhdari; Luis G Bermúdez-Humarán; Jean-Jacques Gratadoux; Sébastien Blugeon; Chantal Bridonneau; Jean-Pierre Furet; Gérard Corthier; Corinne Grangette; Nadia Vasquez; Philippe Pochart; Germain Trugnan; Ginette Thomas; Hervé M Blottière; Joël Doré; Philippe Marteau; Philippe Seksik; Philippe Langella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

7.  Gut microbiome in chronic rheumatic and inflammatory bowel diseases: Similarities and differences.

Authors:  Fatouma Salem; Nadège Kindt; Julian R Marchesi; Patrick Netter; Anthony Lopez; Tunay Kokten; Silvio Danese; Jean-Yves Jouzeau; Laurent Peyrin-Biroulet; David Moulin
Journal:  United European Gastroenterol J       Date:  2019-08-01       Impact factor: 4.623

8.  Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice.

Authors:  Chang Soo Eun; Yoshiyuki Mishima; Steffen Wohlgemuth; Bo Liu; Maureen Bower; Ian M Carroll; R Balfour Sartor
Journal:  Infect Immun       Date:  2014-03-18       Impact factor: 3.441

Review 9.  Use of Short-Chain Fatty Acids for the Recovery of the Intestinal Epithelial Barrier Affected by Bacterial Toxins.

Authors:  Diliana Pérez-Reytor; Carlos Puebla; Eduardo Karahanian; Katherine García
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

10.  High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease.

Authors:  Alan W Walker; Jeremy D Sanderson; Carol Churcher; Gareth C Parkes; Barry N Hudspith; Neil Rayment; Jonathan Brostoff; Julian Parkhill; Gordon Dougan; Liljana Petrovska
Journal:  BMC Microbiol       Date:  2011-01-10       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.